| J1602 | Injection, golimumab, 1 mg, for intravenous use | 34,810 | $10 | $348.1K |
| J9312 | Injection, rituximab, 10 mg | 5,250 | $60 | $330.9K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 7,850 | $30 | $266.9K |
| J3262 | Injection, tocilizumab, 1 mg | 45,840 | $10 | $229.2K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 6,490 | $30 | $162.3K |
| J0897 | Injection, denosumab, 1 mg | 6,540 | $20 | $117.7K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 430 | $90 | $39.3K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 300 | $110 | $31.7K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 320 | $50 | $16.5K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 130 | $130 | $15.9K |